In the SciLifeLab/AstraZeneca collaboration on heart failure, a study has been published in Scientific Reports (https://rdcu.be/boOId) on mRNA expression in myocardial biopsies, obtained from patients undergoing elective coronary bypass surgery, as part of the large study named PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study). The study was led by SciLifeLab researcher Bengt Persson (Uppsala University).
It was found that gene expression data clustered into two groups, corresponding to HFpEF (Heart Failure with preserved Ejection Fraction) and Normal physiology, and 743 differentially expressed genes were identified. The associated top biological functions were cardiac muscle contraction, oxidative phosphorylation, cellular remodelling and matrix organisation. The results also indicate that upstream regulatory events, including inhibition of transcription factors STAT4, SRF and TP53, and activation of transcription repressors HEY2 and KDM5A, could provide explanatory mechanisms to observed gene expression differences and ultimately cardiac dysfunction in the HFpEF proxy group.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.